Evaluation of mold exposure in cystic fibrosis patients' dwellings and allergic bronchopulmonary risk
- PMID: 25612900
- DOI: 10.1016/j.jcf.2015.01.003
Evaluation of mold exposure in cystic fibrosis patients' dwellings and allergic bronchopulmonary risk
Abstract
Very few studies have been conducted on cystic fibrosis (CF) patients' exposure to the indoor environment and, to our knowledge, there are no studies dealing with the link between specific fungal environmental exposure at home and fungal colonization resulting in allergic bronchopulmonary aspergillosis (ABPA). Fungal exposure of CF adult patients with ABPA (n=4) with fungal sensitization (n=7) and with no ABPA (n=5) was assessed in 16 homes by dust sampling with electrostatic dust fall collectors (EDCs). Aspergillus fumigatus was specifically quantified by real-time quantitative polymerase chain reactions (qPCRs), and A. fumigatus DNA concentrations were significantly higher in homes of ABPA patients (p<0.001). Results indicate that indoor fungal contamination could be a factor favoring ABPA and suggest that environmental surveys could help in preventing fungal risk in CF patients.
Keywords: Allergic bronchopulmonary aspergillosis (ABPA); Aspergillus fumigatus; Cystic fibrosis (CF); Dwellings; Real-time quantitative polymerase chain reactions (qPCRs).
Copyright © 2015 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
Comment in
-
Is the home environment an important factor in the occurrence of fungal events in cystic fibrosis?J Cyst Fibros. 2015 Sep;14(5):E16-8. doi: 10.1016/j.jcf.2015.06.008. Epub 2015 Jul 10. J Cyst Fibros. 2015. PMID: 26166287 No abstract available.
-
Replies to "Is the home environment an important factor in the occurrence of fungal events in cystic fibrosis?".J Cyst Fibros. 2016 Mar;15(2):e17-8. doi: 10.1016/j.jcf.2015.12.016. Epub 2016 Jan 6. J Cyst Fibros. 2016. PMID: 26777600 No abstract available.
Similar articles
-
The role of basophil activation test in allergic bronchopulmonary aspergillosis and Aspergillus fumigatus sensitization in cystic fibrosis patients.J Cyst Fibros. 2016 Sep;15(5):587-96. doi: 10.1016/j.jcf.2016.02.004. Epub 2016 Feb 26. J Cyst Fibros. 2016. PMID: 26922860
-
Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.Am J Respir Crit Care Med. 2006 Jun 15;173(12):1370-6. doi: 10.1164/rccm.200508-1271OC. Epub 2006 Mar 16. Am J Respir Crit Care Med. 2006. PMID: 16543550
-
Serum IgE and IgG reactivity to Aspergillus recombinant antigens in patients with cystic fibrosis.J Med Microbiol. 2019 Jun;68(6):924-929. doi: 10.1099/jmm.0.000991. Epub 2019 May 15. J Med Microbiol. 2019. PMID: 31090534
-
Allergic bronchopulmonary mycosis complicating cystic fibrosis.Semin Respir Infect. 1992 Sep;7(3):179-92. Semin Respir Infect. 1992. PMID: 1475542 Review.
-
Serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis: State of the art and further challenges.Med Mycol. 2010 Nov;48 Suppl 1:S77-87. doi: 10.3109/13693786.2010.514301. Med Mycol. 2010. PMID: 21067334 Review.
Cited by
-
AWMF mold guideline "Medical clinical diagnostics for indoor mold exposure" - Update 2023 AWMF Register No. 161/001.Allergol Select. 2024 May 3;8:90-198. doi: 10.5414/ALX02444E. eCollection 2024. Allergol Select. 2024. PMID: 38756207 Free PMC article.
-
Aiming to Improve Equity in Pulmonary Health: Cystic Fibrosis.Clin Chest Med. 2023 Sep;44(3):555-573. doi: 10.1016/j.ccm.2023.03.011. Epub 2023 May 8. Clin Chest Med. 2023. PMID: 37517835 Free PMC article. Review.
-
New Commercially Available IgG Kits and Time-Resolved Fluorometric IgE Assay for Diagnosis of Allergic Bronchopulmonary Aspergillosis in Patients with Cystic Fibrosis.Clin Vaccine Immunol. 2015 Dec 23;23(3):196-203. doi: 10.1128/CVI.00498-15. Clin Vaccine Immunol. 2015. PMID: 26698651 Free PMC article.
-
How to Assess Fungal Contamination of Indoor Air in Dwellings of Patients with Cystic Fibrosis?Mycopathologia. 2025 Jul 6;190(4):62. doi: 10.1007/s11046-025-00968-0. Mycopathologia. 2025. PMID: 40619550
-
Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy.Infect Drug Resist. 2016 Sep 20;9:229-238. doi: 10.2147/IDR.S63621. eCollection 2016. Infect Drug Resist. 2016. PMID: 27703383 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical